Program Content


  • HER2-low ABC
    Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 19, 2023

    Expires: January 18, 2024

    View Activity


cover img faculity

Nadia Harbeck, MD, PhD

Full Professor
Breast Center, LMU University Hospital
Ludwig-Maximilians University
Munich, Germany

cover img faculity

Komal Jhaveri, MD, FACP

Associate Attending
Breast Medicine Service and Early Drug Development Service
Section Head, Endocrine Therapy Research Program
Clinical Director, Early Drug Development Service
Department of Medicine
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner


AstraZeneca Pharmaceuticals

Daiichi Sankyo, Inc.